Glenview Capital Management - Q1 2021 holdings

$5.9 Billion is the total value of Glenview Capital Management's 63 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 58.9% .

 Value Shares↓ Weighting
THC SellTENET HEALTHCARE CORP$713,717,000
-2.1%
13,725,320
-24.8%
12.09%
-27.7%
BHC SellBAUSCH HEALTH COS INC$495,559,000
+45.0%
15,613,090
-5.0%
8.40%
+7.1%
CI BuyCIGNA CORP NEW$449,363,000
+72.0%
1,858,867
+48.1%
7.61%
+27.1%
MCK BuyMCKESSON CORP$343,408,000
+69.1%
1,760,705
+50.8%
5.82%
+24.9%
DXC BuyDXC TECHNOLOGY CO$330,808,000
+26.6%
10,582,485
+4.3%
5.60%
-6.5%
TAK BuyTAKEDA PHARMACEUTICAL CO LTDsponsored ads$294,063,000
+5.9%
16,104,222
+5.5%
4.98%
-21.8%
ABC BuyAMERISOURCEBERGEN CORP$214,188,000
+150.3%
1,814,078
+107.2%
3.63%
+85.0%
HCA SellHCA HEALTHCARE INC$201,610,000
-5.7%
1,070,460
-17.7%
3.42%
-30.3%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$154,618,000
+80.2%
1,159,140
+85.7%
2.62%
+33.1%
FB BuyFACEBOOK INCcl a$144,866,000
+5431.3%
491,855
+5031.0%
2.45%
+3990.0%
GOOGL BuyALPHABET INCcap stk cl a$135,990,000
+173.1%
65,934
+132.1%
2.30%
+101.8%
NUAN BuyNUANCE COMMUNICATIONS INC$134,860,000
+36.7%
3,090,291
+38.1%
2.28%
+1.0%
BSX BuyBOSTON SCIENTIFIC CORP$123,601,000
+27.2%
3,197,966
+18.3%
2.09%
-6.0%
BAX BuyBAXTER INTL INC$116,220,000
+159.2%
1,377,998
+146.6%
1.97%
+91.5%
BKD BuyBROOKDALE SR LIVING INC$109,196,000
+36.9%
18,048,945
+0.2%
1.85%
+1.1%
FISV BuyFISERV INC$104,451,000
+89.6%
877,447
+81.4%
1.77%
+40.1%
FMC BuyFMC CORP$95,090,000
+16.2%
859,688
+20.8%
1.61%
-14.1%
ANTM BuyANTHEM INC$94,631,000
+59.8%
263,633
+42.9%
1.60%
+18.0%
HUM BuyHUMANA INC$81,309,000
+24.3%
193,938
+21.6%
1.38%
-8.1%
BFLY NewBUTTERFLY NETWORK INC$80,361,0004,774,846
+100.0%
1.36%
MYGN SellMYRIAD GENETICS INC$78,239,000
+7.4%
2,569,433
-30.2%
1.33%
-20.6%
CCEP NewCOCA COLA EUROPEAN PARTNERS$71,326,0001,367,451
+100.0%
1.21%
MOH BuyMOLINA HEALTHCARE INC$71,068,000
+80.9%
304,023
+64.6%
1.20%
+33.6%
WBA NewWALGREENS BOOTS ALLIANCE INC$70,812,0001,289,830
+100.0%
1.20%
UNP BuyUNION PAC CORP$70,114,000
+428.4%
318,106
+399.1%
1.19%
+290.8%
ESI SellELEMENT SOLUTIONS INC$70,001,000
+2.1%
3,827,268
-1.0%
1.19%
-24.6%
CTVA BuyCORTEVA INC$65,793,000
+31.8%
1,411,261
+9.4%
1.12%
-2.6%
LH SellLABORATORY CORP AMER HLDGS$56,258,000
-49.9%
220,595
-60.1%
0.95%
-63.0%
V NewVISA INC$53,396,000252,187
+100.0%
0.90%
NSC BuyNORFOLK SOUTHN CORP$53,370,000
+136.6%
198,757
+109.4%
0.90%
+74.9%
GPN BuyGLOBAL PMTS INC$51,779,000
+299.7%
256,866
+327.1%
0.88%
+195.3%
DD BuyDUPONT DE NEMOURS INC$50,532,000
+175.4%
653,888
+153.4%
0.86%
+103.3%
LGVU NewLONGVIEW ACQUISITION CORP IIunit 99/99/9999$50,200,0005,000,000
+100.0%
0.85%
SABR NewSABRE CORP$47,180,0003,185,704
+100.0%
0.80%
DVA BuyDAVITA INC$45,938,000
+178.3%
426,257
+203.1%
0.78%
+105.3%
MSFT BuyMICROSOFT CORP$42,338,000
+669.2%
179,573
+625.6%
0.72%
+469.0%
IQV SellIQVIA HLDGS INC$39,989,000
-34.3%
207,047
-39.0%
0.68%
-51.4%
CAR SellAVIS BUDGET GROUP$36,386,000
-43.4%
501,601
-70.9%
0.62%
-58.2%
ENDP SellENDO INTL PLC$36,090,000
-32.9%
4,870,384
-35.0%
0.61%
-50.4%
TBA NewTHOMA BRAVO ADVANTAGE$34,378,0003,289,715
+100.0%
0.58%
FAII NewFORTRESS VALUE ACQUISITION I$31,933,0003,202,953
+100.0%
0.54%
HOLX SellHOLOGIC INC$31,793,000
-45.7%
427,445
-46.9%
0.54%
-59.9%
MTOR SellMERITOR INC$31,614,000
-58.9%
1,074,567
-61.0%
0.54%
-69.6%
NSP BuyINSPERITY INC$31,537,000
+142.1%
376,606
+135.4%
0.53%
+78.6%
BHVN NewBIOHAVEN PHARMACTL HLDG CO L$31,345,000458,600
+100.0%
0.53%
LYFT SellLYFT INC$29,427,000
-71.0%
465,761
-77.4%
0.50%
-78.5%
DNB BuyDUN & BRADSTREET HLDGS INC$29,399,000
+489.9%
1,234,730
+516.9%
0.50%
+336.8%
APTV BuyAPTIV PLC$29,360,000
+104.4%
212,906
+93.1%
0.50%
+51.1%
VIAC SellVIACOMCBS INCcl b$22,550,000
-54.9%
500,000
-62.7%
0.38%
-66.7%
MAR SellMARRIOTT INTL INC NEWcl a$17,181,000
-43.0%
116,000
-49.3%
0.29%
-57.9%
VELOU NewVELOCITY ACQUISITION CORPunit 99/99/9999$14,790,0001,500,000
+100.0%
0.25%
FLEX NewFLEX LTDord$14,502,000792,012
+100.0%
0.25%
MDT BuyMEDTRONIC PLC$13,599,000
+1.9%
115,116
+1.1%
0.23%
-24.8%
FST NewFAST ACQUISITION CORP$12,457,000995,000
+100.0%
0.21%
CAPA NewHIGHCAPE CAP ACQUISITION COR$12,362,0001,037,091
+100.0%
0.21%
GHVI NewGORES HOLDINGS VI INC$8,419,000614,517
+100.0%
0.14%
PPD NewPPD INC$8,266,000218,446
+100.0%
0.14%
NHIC NewNEWHOLD INVESTMENT CORP$5,506,000550,000
+100.0%
0.09%
OHPAU NewORION ACQUISITION CORPunit 02/19/2026$5,000,000500,000
+100.0%
0.08%
FZTU NewFAST ACQUISITION CORP IIunit 03/16/2026$4,970,000500,000
+100.0%
0.08%
MIK SellMICHAELS COS INC$2,048,000
-92.1%
93,363
-95.3%
0.04%
-94.1%
NBSE NewNEUBASE THERAPEUTICS INC$739,000100,000
+100.0%
0.01%
FAIIWS NewFORTRESS VALUE ACQUISITION I*w exp 08/10/202$474,000300,000
+100.0%
0.01%
AMZN ExitAMAZON COM INC$0-778
-100.0%
-0.06%
URI ExitUNITED RENTALS INC$0-12,804
-100.0%
-0.07%
FLDM ExitFLUIDIGM CORP DEL$0-809,369
-100.0%
-0.11%
ARMK ExitARAMARK$0-186,457
-100.0%
-0.16%
VVI ExitVIAD CORP$0-250,995
-100.0%
-0.21%
PRAH ExitPRA HEALTH SCIENCES INC$0-93,925
-100.0%
-0.27%
DGX ExitQUEST DIAGNOSTICS INC$0-100,567
-100.0%
-0.28%
WELL ExitWELLTOWER INC$0-305,732
-100.0%
-0.45%
PEAK ExitHEALTHPEAK PROPERTIES INC$0-1,042,641
-100.0%
-0.72%
AMGN ExitAMGEN INC$0-141,474
-100.0%
-0.75%
MCK ExitMCKESSON CORPcall$0-200,000
-100.0%
-0.80%
CI ExitCIGNA CORP NEWcall$0-200,000
-100.0%
-0.96%
EXPE ExitEXPEDIA GROUP INC$0-428,895
-100.0%
-1.30%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-17
Signatures

The EDGAR filing(s) were signed by:

About Glenview Capital Management

Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.

Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.

Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.

Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TENET HEALTHCARE CORP42Q3 202316.7%
HCA HOLDINGS INC42Q3 20239.1%
MCKESSON CORP40Q3 20238.2%
FLEXTRONICS INTL LTD38Q2 20234.5%
BROOKDALE SR LIVING INC38Q3 20232.1%
MERITOR INC36Q1 20223.0%
FMC CORP34Q2 20236.4%
UNIVERSAL HLTH SVCS INC34Q3 20235.0%
HUMANA INC31Q4 202112.1%
ENDO INTL PLC30Q1 20222.8%

View Glenview Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Glenview Capital Management Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Butterfly Network, Inc.February 14, 20239,746,8345.5%
Quantum-Si IncFebruary 14, 20234,249,9563.6%
MERITOR, INC.February 22, 20223,544,3335.0%
ATI Physical Therapy, Inc.Sold outFebruary 14, 202200.0%
Evolv Technologies Holdings, Inc.February 14, 2022749,4610.5%
Velocity Acquisition Corp.Sold outFebruary 14, 202200.0%
Bausch Health Companies Inc.December 13, 202117,078,6574.8%
NewHold Investment Corp.June 04, 20211,114,8626.5%
Longview Acquisition Corp. IIApril 02, 20215,000,0007.2%
HighCape Capital Acquisition Corp.March 15, 20211,033,7398.7%

View Glenview Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-16
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15

View Glenview Capital Management's complete filings history.

Compare quarters

Export Glenview Capital Management's holdings